MARSHALL WACE, LLP - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 41 filers reported holding GALERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$993,788
+112.5%
318,522
+74.4%
0.00%
+100.0%
Q1 2023$467,633
+987.5%
182,669
+914.6%
0.00%
Q1 2022$43,000
-48.8%
18,004
-2.1%
0.00%
Q4 2021$84,000
-87.5%
18,382
-77.9%
0.00%
-100.0%
Q3 2021$673,000
-41.2%
83,050
-28.7%
0.00%
-40.0%
Q2 2021$1,145,000
+139.5%
116,508
+115.3%
0.01%
+150.0%
Q1 2021$478,00054,1140.00%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 613,223$913,7020.63%
SECTORAL ASSET MANAGEMENT INC 1,666,666$2,483,3320.48%
Sofinnova Investments, Inc. 3,083,712$4,594,7310.27%
Novo Holdings A/S 2,459,021$3,663,9410.23%
Tekla Capital Management LLC 898,374$1,338,5770.05%
Blackstone Inc. 1,678,984$2,501,6860.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 187,000$278,6300.01%
Ensign Peak Advisors, Inc 151,777$226,1480.00%
TCI Wealth Advisors, Inc. 6,162$9,1810.00%
Tower Research Capital LLC (TRC) 17,819$270.00%
View complete list of GALERA THERAPEUTICS INC shareholders